Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf vs Envarsus in Liver Transplantation
NCT03603548Unknown
- Sponsor
- Medical University of Warsaw
- Start
- Jul 2018
- Primary completion
- Jul 2023
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tacrolimus in Liver transplant rejection (2 arms), sponsored by Medical University of Warsaw. Primary endpoints: Acute Rejection at 12 months, Chronic Rejection at 5 years and 2 more. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT03603548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03603548.